Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Dermatologic ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Selective sweat gland removal with minimal skin excision in the treatment of axillary hyperhidrosis: a retrospective clinical and histological review of 15 patients.Br J Dermatol. 2006; 155: 115-118https://doi.org/10.1111/j.1365-2133.2006.07320.x
- Characteristics of refractory sweating areas following minimally invasive surgery for axillary hyperhidrosis.Aesthetic Plast Surg. 2008; 33: 308-311https://doi.org/10.1007/s00266-008-9261-4
- Tumescent suction curettage versus minimal skin resection with subcutaneous curettage of sweat glands in axillary hyperhidrosis.Dermatol Surg. 2008; 34: 709-716https://doi.org/10.1111/j.1524-4725.2008.34132.x
- Histological and clinical findings in different surgical strategies for focal axillary hyperhidrosis: histologic and clinical findings.Dermatol Surg. 2008; 34: 1001-1009https://doi.org/10.1111/j.1524-4725.2008.34198.x
- Management of primary hyperhidrosis: a summary of the different treatment modalities.Am J Clin Dermatol. 2003; 4: 681-697
- Surgical treatment of axillary hyperhidrosis: a study comparing liposuction cannulas with a suction-curettage cannula.Ann Plast Surg. 2006; 56: 654-657https://doi.org/10.1097/01.sap.0000205771.40918.b3
- Liposuction for axillary hyperhidrosis.Australas J Dermatol. 2005; 46: 76-79
- Treatment of axillary hyperhidrosis: combination of the starch-iodine test with the tumescent liposuction technique.Dermatol Surg. 2000; 26: 392-396
- Repeat liposuction-curettage treatment of axillary hyperhidrosis is safe and effective.Br J Dermatol. 2007; 157: 739-743https://doi.org/10.1111/j.1365-2133.2007.08092.x
- The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial.J Am Acad Dermatol. 2013; 69: 88-95https://doi.org/10.1016/j.jaad.2013.02.013
- Aggressive shaving after combined liposuction and curettage for axillary hyperhidrosis leads to more complications without further benefit.Dermatol Surg. 2008; 34: 952-953https://doi.org/10.1111/j.1524-4725.2008.34185.x
- Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis.J Eur Acad Dermatol Venereol. 2001; 15: 207-211
- Gravimetrically controlled efficacy of subcorial curettage: a prospective study for treatment of axillary hyperhidrosis.Dermatol Surg. 2002; 28: 1022-1026
- Treatment of hyperhidrosis with microwave technology.Semin Cutan Med Surg. 2013; 32: 2-8
- Microwave thermolysis of sweat glands.Lasers Surg Med. 2012; 44: 20-25https://doi.org/10.1002/lsm.21142
- Clinical evaluation of a microwave device for treating axillary hyperhidrosis.Dermatol Surg. 2012; 38: 728-735https://doi.org/10.1111/j.1524-4725.2012.02375.x
- A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study.Dermatol Surg. 2012; 38: 185-191https://doi.org/10.1111/j.1524-4725.2011.02250.x
- The efficacy of a microwave device for treating axillary hyperhidrosis and osmidrosis in Asians: a preliminary study.J Cosmet Laser Ther. 2013; 15: 255-259https://doi.org/10.3109/14764172.2013.807114
- Tumescent suction curettage vs. curettage only for treatment of axillary hyperhidrosis evaluated by subjective and new objective methods.Acta Derm Venereol. 2013; 94: 215-220https://doi.org/10.2340/00015555-1671
Article info
Publication history
Published online: July 29, 2014
Footnotes
Disclosure: D.A. Glaser has served as advisor for Allergan, Galderma, Miramar Labs, and Unilever. She has been an investigator and received research grants from Allergan, Miramar Labs, and Ulthera. T.A. Galperin has nothing to disclose.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
